ArticleHealth data science2025

Comparative Assessment of Pivotal Trials Supporting the Indication Approvals of Innovative and Modified New Anticancer Drugs in China, 2016-2022.

Lixia Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.